170 related articles for article (PubMed ID: 29498802)
21. Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.
Michalak EM; Jansen ES; Happo L; Cragg MS; Tai L; Smyth GK; Strasser A; Adams JM; Scott CL
Cell Death Differ; 2009 May; 16(5):684-96. PubMed ID: 19148184
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment.
Schenk RL; Tuzlak S; Carrington EM; Zhan Y; Heinzel S; Teh CE; Gray DH; Tai L; Lew AM; Villunger A; Strasser A; Herold MJ
Cell Death Differ; 2017 Mar; 24(3):534-545. PubMed ID: 28085150
[TBL] [Abstract][Full Text] [Related]
23. Perturbation of B-cell development in mice overexpressing the Bcl-2 homolog A1.
Chuang PI; Morefield S; Liu CY; Chen S; Harlan JM; Willerford DM
Blood; 2002 May; 99(9):3350-9. PubMed ID: 11964303
[TBL] [Abstract][Full Text] [Related]
24. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
[TBL] [Abstract][Full Text] [Related]
25. MYC levels govern hematopoietic tumor type and latency in transgenic mice.
Smith DP; Bath ML; Metcalf D; Harris AW; Cory S
Blood; 2006 Jul; 108(2):653-61. PubMed ID: 16537801
[TBL] [Abstract][Full Text] [Related]
26. The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.
Hunter JE; Butterworth JA; Zhao B; Sellier H; Campbell KJ; Thomas HD; Bacon CM; Cockell SJ; Gewurz BE; Perkins ND
Oncogene; 2016 Jun; 35(26):3476-84. PubMed ID: 26522720
[TBL] [Abstract][Full Text] [Related]
27. Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase.
Turner SD; Tooze R; Maclennan K; Alexander DR
Oncogene; 2003 Oct; 22(49):7750-61. PubMed ID: 14586401
[TBL] [Abstract][Full Text] [Related]
28. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
29. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Wang J; Boxer LM
J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
[TBL] [Abstract][Full Text] [Related]
30. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.
Egle A; Harris AW; Bath ML; O'Reilly L; Cory S
Blood; 2004 Mar; 103(6):2276-83. PubMed ID: 14630790
[TBL] [Abstract][Full Text] [Related]
31. Myc suppression of Nfkb2 accelerates lymphomagenesis.
Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
[TBL] [Abstract][Full Text] [Related]
32. Critical B-lymphoid cell intrinsic role of endogenous MCL-1 in c-MYC-induced lymphomagenesis.
Grabow S; Kelly GL; Delbridge AR; Kelly PN; Bouillet P; Adams JM; Strasser A
Cell Death Dis; 2016 Mar; 7(3):e2132. PubMed ID: 26962682
[TBL] [Abstract][Full Text] [Related]
33. Perforin-mediated suppression of B-cell lymphoma.
Bolitho P; Street SE; Westwood JA; Edelmann W; Macgregor D; Waring P; Murray WK; Godfrey DI; Trapani JA; Johnstone RW; Smyth MJ
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2723-8. PubMed ID: 19196996
[TBL] [Abstract][Full Text] [Related]
34. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
[TBL] [Abstract][Full Text] [Related]
35. Generation and evaluation of an IPTG-regulated version of Vav-gene promoter for mouse transgenesis.
Grespi F; Ottina E; Yannoutsos N; Geley S; Villunger A
PLoS One; 2011 Mar; 6(3):e18051. PubMed ID: 21445314
[TBL] [Abstract][Full Text] [Related]
36. Constitutive expression of the anti-apoptotic Bcl-2 family member A1 in murine endothelial cells leads to transplant tolerance.
Smyth LA; Meader L; Xiao F; Woodward M; Brady HJ; Lechler R; Lombardi G
Clin Exp Immunol; 2017 May; 188(2):219-225. PubMed ID: 28120329
[TBL] [Abstract][Full Text] [Related]
37. Dysregulated TRAF3 and BCL2 Expression Promotes Multiple Classes of Mature Non-hodgkin B Cell Lymphoma in Mice.
Perez-Chacon G; Adrados M; Vallejo-Cremades MT; Lefebvre S; Reed JC; Zapata JM
Front Immunol; 2018; 9():3114. PubMed ID: 30687320
[TBL] [Abstract][Full Text] [Related]
38. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
[TBL] [Abstract][Full Text] [Related]
39. Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy.
Sochalska M; Tuzlak S; Egle A; Villunger A
FEBS J; 2015 Mar; 282(5):834-849. PubMed ID: 25559680
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.
Eischen CM; Woo D; Roussel MF; Cleveland JL
Mol Cell Biol; 2001 Aug; 21(15):5063-70. PubMed ID: 11438662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
